Filing Details

Accession Number:
0001127602-15-024143
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-04 17:29:03
Reporting Period:
2015-08-03
Filing Date:
2015-08-04
Accepted Time:
2015-08-04 17:29:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376545 G Gordon Pugh 852 Winter St.
Waltham MA 02451
Svp, Coo & Cro, Alkermes, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-08-03 13,750 $16.55 27,860 No 4 M Direct
Ordinary Shares Disposition 2015-08-03 810 $69.53 27,050 No 4 S Direct
Ordinary Shares Disposition 2015-08-03 12,640 $70.10 14,410 No 4 S Direct
Ordinary Shares Disposition 2015-08-03 300 $70.73 14,110 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2015-08-03 13,750 $0.00 13,750 $16.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,500 2013-05-21 2022-05-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 30,637 Indirect Gordon G. Pugh Revocable Trust - 2012
Ordinary Shares 9,190 Indirect By GRAT
Ordinary Shares 10,900 Indirect Nancy E. Pugh Revocable Trust - 2012
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.68 to $69.63. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.73 to $70.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. Shares held by KAS Grantor Retained Annuity Trust dated December 16, 2014 (the "GRAT"). The Reporting Person's spouse is a trustee and beneficiary of the GRAT.
  6. Shares subject to the stock option award vest in four equal annual installments commencing on 5/21/13.